Histopathologic Subtype as a Determinant of Prognosis and Chemotherapy Benefit in Resected Ampullary Adenocarcinoma
Histopathologic subtype is a key prognostic factor in AAC, with AC associated with better survival in pbAAC.
Authors
- Karla Navarrete Gálvez
- Salvador Rodriguez Franco (ORCID: https://orcid.org/0000-0001-9786-3651)
- Atsushi Nara (ORCID: https://orcid.org/0000-0001-9233-8911)
- Riccardo Pellegrini (ORCID: https://orcid.org/0009-0006-0597-9360)
- M. Del Chiaro
- Valentina Del Chiaro
- Hiroyuki Ishida
- Benedetto Mungo
- Richard D. Schulick
Institutions
- Kansai Medical University (JP)
- University of Padua (IT)
- Tokyo Institute of Psychiatry (JP)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of Hepato-Biliary-Pancreatic Sciences
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1002/jhbp.70100
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00